Compounds > gabexate
Page last updated: 2024-10-27

gabexate and Genetic Predisposition

gabexate has been researched along with Genetic Predisposition in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Stopsack, KH1
Mucci, LA1
Antonarakis, ES1
Nelson, PS1
Kantoff, PW1

Reviews

1 review available for gabexate and Genetic Predisposition

ArticleYear
    Cancer discovery, 2020, Volume: 10, Issue:6

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Esters; Female; Gabexate; Gene Expression Regulat

2020